I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| conventional dendritic cell | 22 studies | 35% ± 14% | |
| non-classical monocyte | 19 studies | 39% ± 17% | |
| classical monocyte | 16 studies | 31% ± 14% | |
| pericyte | 14 studies | 26% ± 11% | |
| macrophage | 12 studies | 28% ± 8% | |
| monocyte | 12 studies | 29% ± 10% | |
| dendritic cell | 8 studies | 57% ± 18% | |
| myeloid cell | 8 studies | 35% ± 20% | |
| smooth muscle cell | 7 studies | 32% ± 9% | |
| hematopoietic precursor cell | 5 studies | 28% ± 10% | |
| erythroblast | 5 studies | 34% ± 16% | |
| endothelial cell | 5 studies | 24% ± 6% | |
| mononuclear phagocyte | 3 studies | 42% ± 19% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 16% ± 0% | |
| leukocyte | 3 studies | 31% ± 12% | |
| myofibroblast cell | 3 studies | 28% ± 6% | |
| common myeloid progenitor | 3 studies | 35% ± 6% | |
| alveolar macrophage | 3 studies | 18% ± 2% | |
| epithelial cell | 3 studies | 30% ± 6% | |
| fibroblast | 3 studies | 28% ± 2% | |
| connective tissue cell | 3 studies | 41% ± 25% | |
| CD4-positive, alpha-beta T cell | 3 studies | 24% ± 8% | |
| basal cell | 3 studies | 21% ± 4% |
